Hasil Pencarian - M. Ulrickson

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    Outcomes of endemic Burkitt lymphoma patients treated using a patient-oriented approach

    Outcomes of endemic Burkitt lymphoma patients treated using a patient-oriented approach oleh I. Mutyaba, S. McGoldrick, E. Krantz, M. Ulrickson, S. Gerdts, A. Omoding, F. Geriga, J.B. Kambugu, J. Orem, C. Casper

    Diterbitkan 2016-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY

    P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14... oleh P. Strati, L. Leslie, P. Shiraz, E. Budde, O. O. Oluwole, M. Ulrickson, A. Ramakrishnan, J. Sun, R. Shen, J. Kanska, P. McCroskery, J. Dong, M. Schupp, H. Xu, K. Patel

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VS STANDARD-OF-CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (ZUMA-7)

    S211: CLINICAL AND PATIENT-REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VS STANDARD-OF-CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL L... oleh A. Sureda, J. Westin, F. L. Locke, M. Dickinson, A. Ghobadi, M. Elsawy, T. van Meerten, D. B. Miklos, M. Ulrickson, M.-A. Perales, U. Farooq, L. Wannesson, L. Leslie, M. J. Kersten, C. A. Jacobson, J. M. Pagel, G. Wulf, P. Johnston, A. P. Rapoport, L. I. Gordon, Y. Yang, A. Peng, L. Du, J. T. Snider, J. Shah, M. Schupp, P. Cheng, C. To, O. O. Oluwole

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: